Thales, European Leader in Quantum Physics and Artificial Intelligence, Opens InnovDays 2019
27.11.2019 20:36:00 EET | Business Wire | Press release
Thales launched InnovDays in 2012 as a way for its customers and partners to gain exclusive insights into the technological excellence of its research facilities. Since then, successive InnovDays events have turned the spotlight on the latest technological innovations developed by more than 29,500 Thales engineers and researchers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191127005575/en/
Thales InnovDays 2019 (Photo: Thales)
InnovDays: building a trusted future through science
InnovDays is a reflection of Thales's objective of leveraging science and high technology to build a future we can all trust. By harnessing the unprecedented precision and power of quantum physics and augmenting the performance of its systems thanks to artificial intelligence, Thales is developing the new generation of technologies that will shape the world of tomorrow.
"InnovDays is an illustration of Thales's outstanding technological capabilities and the passion displayed by our 29,500 engineers for helping our customers step up to society's major challenges through innovation." Marko Erman, Chief Technology Officer.
As an expert in critical systems, Thales is conducting in-depth research into both digital technologies and deep tech solutions to develop a portfolio of products based on a common core of technological building blocks. At InnovDays on 27, 28 and 29 November 2019, Thales will present a total of 70 practical applications of this research centred around the following themes:
Round tables:
-
Thursday 28 November:
- 8.30 am: How can we make AI trustable?
- 1.30 pm: Sovereignty in the digital age
-
Friday 29 November:
- 8.30 am: High tech and climate change: friend or foe?
- 11.00 am: The strategy and the future of air transport
- 1.30 pm: The second quantum revolution starts now!
Star guests from the world of science and industry will be taking part in these round table sessions, including Albert Fert (Nobel Prize in Physics 2007), Jean-Marc Jancovici (Founder and President of The Shift Project), Alexandre de Juniac (IATA Director General and CEO) and Pascale Senellart (research director at the Centre for Nanoscience and Nanotechnology, Paris-Saclay University, Paris-Sud University, CNRS).
Proposed press tours at InnovDays 2019
- Tomorrow's cities
- The future of transport
- Biometrics
- The Cloud
- Big Data
- Tomorrow's connectivity in the civil world
- Tomorrow's connectivity in the world of defence
- Air defence of the future
- Land and naval defence of the future
- The augmented soldier
- Secure identities and data for citizens and businesses
|
On 27, 28 and 29 November 2019, the Thales YouTube channel will feature live coverage of the round table sessions and some of the most popular demonstrations. |
From sensors that are up to 10,000 more accurate to ultra-secure communications, quantum technologies are set to push back the boundaries of physics and unleash previously unexploited properties of matter.
An aircraft flying from Paris to New York with only an inertial navigation system to guide it could determine its location to within a few kilometres. With future quantum sensors, it could land with a precision of within a metre. In other fields, quantum sensors could detect tumours that are invisible today, or provide a basis for developing new sources of energy.
Quantum physics relies on radically new concepts and ways of manipulating matter. Quantum sensors, like quantum communications and quantum computing, are currently under the microscope in the laboratories operated by Thales and its academic partners (CNRS, Université Paris-Saclay, etc.) at the Saclay research and technology cluster, south of Paris.
On 26 November 2019, Thales and its academic and research partners are organising a presentation at Saclay to highlight European excellence in quantum research: from cold atoms to flawed diamonds and superconductors, scientific progress in quantum physics has the potential to harness unexploited properties of matter and unleash a whole host of new opportunities.
Thales is working on these new properties to develop the next generation of quantum sensors, relying on the exact same technological building blocks as quantum computers. Quantum encryption too, could soon lead to communication systems that are completely secure and trustworthy.
Thales has also been selected to take part in the European OPENQKD initiative as part of the Austrian Institute of Technology (AIT) consortium chosen by the European Commission to install infrastructure in several European countries to test quantum communication networks.
Navigating intelligently among millions of aircraft movements: Thales presents the brain of tomorrow's aircraft.
Ultimately, quantum technologies will provide untold benefits for avionics systems, including order-of-magnitude improvements in navigation precision. But the immediate truth is that solutions are needed now to deal with the growth in air traffic, which is expected to have doubled by 2030.
This is the thinking behind PureFlyt, developed by Thales as the brain of tomorrow's aircraft, a fully connected cockpit that will significantly increase aircraft performance.
PureFlyt will be unveiled in Toulouse on 25 November. One of the core innovations that makes PureFlyt a game-changer is its ability to draw on both onboard and open-world data, such as weather information, so that the aircraft trajectory can be permanently controlled, adapted and enhanced, resulting in optimised flight, decreased fuel consumption and a better flying experience for both passengers and crew.
|
About Thales Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €19 billion in 2018 (on a pro forma basis including Gemalto). Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments. |
PLEASE VISIT
Thales Group
Download photos
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191127005575/en/
Contact information
PRESS
Thales, Media relations
Cédric Leurquin
+33 (0)1 57 77 90 93
cedric.leurquin@thalesgroup.com
Thales, Media relations
Alice Pruvot
+331 57 77 89 52
alice.pruvot@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
